Clinical Trials Browser

Withdrawn × Multiple Myeloma × Zoledronic Acid × Clear all

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00242528 2015-04-14

Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.

Phase 4 Withdrawn

Multiple Myeloma